3 EU Countries Suspend AstraZeneca Covid-19 Shots




Laila Afifa

16 March 2021 21:46 WIB

A nurse fills a syringe with the AstraZeneca Covid-19 vaccine at a health care centre in Seoul on February 26, 2021, as South Korea starts coronavirus vaccination campaign. Jung Yeon-je/Pool via REUTERS

TEMPO.CO, Berlin - Three European nations, namely Germany, France and Italy, said on Monday, March 15, they would suspend AstraZeneca COVID-19 shots. This was announced after several countries reported possible serious side-effects, even though the World Health Organization (WHO) said there was no proven link and people should not panic.

Still, the decision by the European Union’s three biggest countries to put inoculations with the AstraZeneca shot on hold threw the already struggling vaccination campaign in the 27-nation EU into disarray.

Denmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots and a low platelet count. Iceland and Bulgaria followed suit and Ireland and the Netherlands announced suspensions on Sunday.

Spain will stop using the vaccine for at least 15 days, Cadena Ser radio reported, citing unnamed sources.

The top WHO scientist reiterated on Monday that there have been no documented deaths linked to COVID-19 vaccines.

“We do not want people to panic,” Soumya Swaminathan said on an online media briefing, adding there has been no association, so far, pinpointed between so-called “thromboembolic events” reported in some countries and COVID-19 shots.

WHO chief Tedros Adhanom Ghebreyesus said an advisory committee meeting on AstraZeneca would be held on Tuesday. EU medicines regulator EMA will also convene this week to assess the information gathered into whether the AstraZeneca shot contributed to thromboembolic events in those inoculated.

The moves by some of Europe’s largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca’s.

Germany warned last week it was facing a third wave of infections, Italy is intensifying lockdowns and hospitals in the Paris region are close to being overloaded.

German Health Minister Jens Spahn said that although the risk of blood clots was low, it could not be ruled out.

“This is a professional decision, not a political one,” Spahn said, adding he was following a recommendation of the Paul Ehrlich Institute, Germany’s vaccine regulator.

EU regulator to meet on Thursday to discuss AstraZeneca vaccine
France said it was suspending the vaccine’s use pending an assessment by EMA.

“The decision taken, in conformity also with our European policy, is to suspend, out of precaution, vaccination with the AZ shot, hoping that we can resume quickly if the EMA’s guidance allows,” French President Emmanuel Macron said.

Italy said its halt was a “precautionary and temporary measure” pending EMA’s ruling.

“The EMA will meet soon to clarify any doubts so that the AstraZeneca vaccine can be resumed safely in the vaccination campaign as soon as possible,” said Gianni Rezza, Director General of Prevention at Italy’s Ministry of Health.

Austria and Spain have stopped using particular batches and prosecutors in the northern Italian region of Piedmont earlier seized 393,600 doses following the death of a man hours after he was vaccinated. It was the second region to do so after Sicily, where two people had died shortly after having their shots.

The WHO appealed to countries not to suspend vaccinations against a disease that has caused more than 2.7 million deaths worldwide. WHO Director-General Tedros said systems were in place to protect public health.

“This does not necessarily mean these events are linked to COVID-19 vaccination, but it’s routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place,” he told the media briefing.

The United Kingdom said it had no concerns, while Poland said it thought the benefits outweighed any risks.

The EMA has said that as of March 10, a total of 30 cases of blood clotting had been reported among close to 5 million people vaccinated with the AstraZeneca shot in the European Economic Area, which links 30 European countries.

Michael Head, a senior research fellow in global health at the University of Southampton, said the decisions by France, Germany and others looked baffling.

“The data we have suggests that numbers of adverse events related to blood clots are the same (and possibly, in fact lower) in vaccinated groups compared to unvaccinated populations,” he said, adding that halting a vaccination program had consequences.

“This results in delays in protecting people, and the potential for increased vaccine hesitancy, as a result of people who have seen the headlines and understandably become concerned. There are no signs yet of any data that really justify these decisions.”

A senior German infectious diseases physician, however, said the background incidence of 2-5 thromboses per million per year was significantly lower than the number of 7 out of 1.6 million vaccinated people cited by Germany’s health ministry.

“This should be the reason to suspend the vaccination in Germany until all cases, including suspected cases in Germany and Europe, have been completely cleared up,” said Clemens Wendtner, head of the special unit for highly contagious life threatening infections at the Schwabing Clinic in Munich.

AstraZeneca’s shot was among the first and cheapest to be developed and launched at volume since the coronavirus was first identified in central China at the end of 2019, and is set to be the mainstay of vaccination program in much of the developing world.

Thailand announced plans on Monday to go ahead with the Anglo-Swedish firm’s shot after suspending its use on Friday, but Indonesia said it would wait for the WHO to report.

The WHO said its advisory panel was reviewing reports related to the shot and would release its findings as soon as possible. But it said it was unlikely to change its recommendations, issued last month, for widespread use, including in countries where the South African variant of the virus may reduce its efficacy.

The EMA has also said there was no indication the events were caused by the vaccination and that the number of reported blood clots was no higher than seen in the general population.

AstraZeneca said earlier it had conducted a review covering more than 17 million people vaccinated in the EU and the UK which had shown no evidence of an increased risk of blood clots.

Long-awaited results from AstraZeneca’s 30,000-person U.S. vaccine trial are now being reviewed by independent monitors to determine whether the shot is safe and effective, a top U.S. official said on Monday.

Read: Europe Plans to Fast Track Variant-modified COVID Vaccines


Indonesian Health Ministry Warns of Marburg Virus

23 jam lalu

Indonesian Health Ministry Warns of Marburg Virus

The Indonesian Government issues a circular on precautions for Marburg virus disease.

European Union Ambassador to Indonesia: We Must Be Fair to Trading Partners

8 hari lalu

European Union Ambassador to Indonesia: We Must Be Fair to Trading Partners

EUDR passed by the European Parliament on December 6 with the view to ensure that each commodity traded in the EU market is legal.

Health Minister on Mask Mandate: We No Longer Regulate It

15 hari lalu

Health Minister on Mask Mandate: We No Longer Regulate It

Indonesian Health Minister Budi Gunadi Sadikin states that his side has no longer specifically regulated the use of face masks in public places.

Jakarta Forecasts Hike in COVID-19 Cases in Next One, Two Weeks

16 hari lalu

Jakarta Forecasts Hike in COVID-19 Cases in Next One, Two Weeks

The Jakarta Health Agency predicted that COVID-19 cases would increase in the next one to two weeks.

Health Ministry Warns of Bird Flu Symptoms

21 hari lalu

Health Ministry Warns of Bird Flu Symptoms

The Health Ministry stated that Indonesia has the world's highest human death toll from H5N1 bird flu.

Health Ministry Adds IndoVac to Second Booster Vaccine List

21 hari lalu

Health Ministry Adds IndoVac to Second Booster Vaccine List

Indonesian Health Ministry added the country's first homegrown COVID-19 vaccine, IndoVac, to the vaccine list for the second booster vaccination.

Jakarta Records 34 Patients Infected with COVID-19 Orthrus Variant

29 hari lalu

Jakarta Records 34 Patients Infected with COVID-19 Orthrus Variant

Jakarta Health Agency records 34 people infected with the latest COVID-19 omicron subvariant CH.1.1 or Orthrus.

WHO Warns of Worrying Bird Flu Situation

32 hari lalu

WHO Warns of Worrying Bird Flu Situation

The World Health Organization is working with Cambodian authorities after two confirmed human cases of H5N1 bird flu were found among one family in th

Covid Boosters Still Free But Govt Mulls Options for Paid System

47 hari lalu

Covid Boosters Still Free But Govt Mulls Options for Paid System

Minister Budi says that the second booster vaccination for adults is still free of charge nationwide.

Singapore Relaxes Covid-19 Travel Curbs

47 hari lalu

Singapore Relaxes Covid-19 Travel Curbs

Singapore is expecting the tourism sector to recover to pre-pandemic levels by 2024.